Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib

The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib

FromThe Oncology Podcast


The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib

FromThe Oncology Podcast

ratings:
Length:
51 minutes
Released:
Oct 7, 2021
Format:
Podcast episode

Description

The Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 51 in our series The Oncology Journal Club.Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they review an eclectic mix of papers covering prostate cancer screening, ASCO guidelines for immunotherapy for locally advanced esophageal carcinoma, infigratinib in advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements, Quick Bites, Zoom Fatigue and much, much more!We hope you enjoy the Amazing Article of the Week, the Practice Tip of the Week and have a few laughs too.Full bios and the list of all papers discussed are available on our website.For the latest oncology news visit www.oncologynews.com.au and for regular oncology updates for healthcare professionals, subscribe for free to get the weekly The Oncology Newsletter.The Oncology Podcast - An Australian Oncology Perspective
Released:
Oct 7, 2021
Format:
Podcast episode

Titles in the series (100)

The Oncology Podcast and The Oncology Journal Club are brought to you by Oncology News Australia, part of the Oncology Media Group. OMG are producers of digital resources to support busy oncology health professionals. For more information and to subscribe to "The Oncology Newsletter" visit our website www.oncologynews.com.au.